Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 02 Aug 2021 |
2 | Reply to Exam Report (MIS-R) | 20 Dec 2021 |
3 | Authorization Letter | 26 Jul 2023 |
3 | Documents in support of Show cause Hearing (SCH) | 26 Jul 2023 |
4 | Authorization Letter | 26 Jul 2023 |
4 | Documents in support of Show cause Hearing (SCH) | 26 Jul 2023 |
5 | Journal Copy | 17 Nov 2023 |
6 | TM-O(NOTICE OF OPPOSITION) | 04 Dec 2023 |
7 | Annexure -1 under rule 46 | 23 May 2024 |
7 | Evidence Affidavit Under Rule 46 (TOP) | 23 May 2024 |
8 | Annexure -1 under rule 46 | 23 May 2024 |
8 | Evidence Affidavit Under Rule 46 (TOP) | 23 May 2024 |
1 | Hearing Notice (Show Cause) | 15459848 | 20 Jun 2023 | |
2 | Tribunal Accepted Notice for : 5070765 | 15740433 | 6091539 | 01 Aug 2023 |
3 | Opposition Notice | 16732482 | 6372561 | 05 Dec 2023 |
4 | Opposition Counter Statement | 17307606 | 6521381 | 05 Feb 2024 |
As per IP India data the trademark was applied on 02 August 2021.
ZUVENTUS HEALTHCARE applied for Dapaformin.
Listed class of trademark Dapaformin is 5.
Dapaformin is on the Opposed stage of the trademark process.
Serial Number provided to trademark application is 5070765
Trademark application was filed by the following attorney agent:
Aditya & Associates
The trademark is categorized as WORD.